Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer

BACKGROUND: Cervical cancer is one of the most common types of gynecological malignancies worldwide. This study aims to develop an immune signature to predict survival in cervical cancer. METHOD: The gene expression data of 296 patients with cervical cancer from The Cancer Genome Atlas database (TCG...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu, Lin, Hao, Pi, Ya-Nan, Chen, Xi-Xi, Zhou, Hu, Tian, Yuan, Zhao, Wei-Dong, Xia, Bai-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029986/
https://www.ncbi.nlm.nih.gov/pubmed/33842318
http://dx.doi.org/10.3389/fonc.2021.616530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029986/
https://www.ncbi.nlm.nih.gov/pubmed/33842318
http://dx.doi.org/10.3389/fonc.2021.616530

Ejemplares similares